VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


ASCO Updates Metastatic Lung Cancer Therapy Guideline to Include Targeted Agents, Early Palliative Care

ASCO Updates Metastatic Lung Cancer Therapy Guideline to Include Targeted Agents, Early Palliative Care

ASCO updates the metastatic lung cancer guideline to include the early integration of palliative care for patients with stage 4 non-small cell lung cancer.

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Severity of Oxaliplatin-induced Neuropathy in Cycle One Predicts Severity, Development of Neurotoxicity

Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.

Dasatinib-induced Pulmonary Hypertension in Patients With Leukemia

Dasatinib-induced Pulmonary Hypertension in Patients With Leukemia

Ultimately, pulmonary arterial hypertension may occur in as many as 5% of patients with leukemia being treated with dasatinib.

Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable

Multigene Panel Testing for Breast, Ovarian Cancer Clinically Valuable

Multigene panel testing can identify mutations that warrant management changes in patients who lack BRCA1 and 2.

PRO-CTCAE Provides "Missing Patient Voice" in Reporting Cancer Treatment Symptoms

PRO-CTCAE Provides "Missing Patient Voice" in Reporting Cancer Treatment Symptoms

A prescription drug's label AE section is almost entirely based on clinicians' impression of patients' symptoms, not the patients' own reports.

Risk Stratification Could Make Colorectal Cancer Screening More Efficient

Risk Stratification Could Make Colorectal Cancer Screening More Efficient

Scoring system may identify patients who do not need colonoscopy to screen for colorectal cancer (CRC).

Radio Frequency Ablation May Produce More Favorable Outcomes in Papillary Neoplasms

Radio Frequency Ablation May Produce More Favorable Outcomes in Papillary Neoplasms

Tumor histology may be an important predictor of how successful treatment with radiofrequency ablation will be, according to a recent study.

Early Docetaxel With ADT Improves Survival in Metastatic Prostate Cancer

Early Docetaxel With ADT Improves Survival in Metastatic Prostate Cancer

New studies suggest that docetaxel initiated at the beginning of ADT resulted in improved cancer control than treatment with ADT alone.

Better Preoperative Coordination of Care Needed for Patients With Lung Cancer

Better Preoperative Coordination of Care Needed for Patients With Lung Cancer

Study finds lung cancer patients miss critical diagnostic tests and often wait too long for treatment.

IMWG Revises International Staging System for Multiple Myeloma

IMWG Revises International Staging System for Multiple Myeloma

The revised ISS should be used in future clinical studies to effectively stratify for newly diagnosed multiple myeloma by relative risk for survival.

Combination Therapy May Benefit Patients With BRAF V600E/K Mutation-Positive Melanoma

Combination Therapy May Benefit Patients With BRAF V600E/K Mutation-Positive Melanoma

Combination therapy with trametinib and dabrafenib resulted in significant reduction in risk of disease progression, death compared to dabrafenib alone.

Combining Aromatase Inhibitors, Bisphosphonates May Benefit Women With Breast Cancer

Combining Aromatase Inhibitors, Bisphosphonates May Benefit Women With Breast Cancer

The use of combination aromatase inhibitors with bisphosphonates could help reduce breast cancer mortality in postmenopausal women.

Concerns Raised Regarding Delays in Mandatory Drug Death Reporting

Concerns Raised Regarding Delays in Mandatory Drug Death Reporting

One in every 10 serious adverse drug events, including deaths, was not reported to the FDA within regulation timelines.

ASCO Statement on Increasing the Number of Older Patients in Clinical Trials

ASCO Statement on Increasing the Number of Older Patients in Clinical Trials

While most cancer drugs are prescribed to older adults, they are underrepresented in clinical trials.

Unregulated E-Cigarettes Called Unacceptable by ASCO

Unregulated E-Cigarettes Called Unacceptable by ASCO

Despite reports to the FDA regarding adverse events of e-cigarettes and concerns from health organizations, sales continue without regulatory oversight.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs